Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells
Wei Huang, Xia Yuan, Ting Sun, Shujie Fan, Jun Wang, Quan Zhou, Wei Guo, Fuxiang Ran, Zemei Ge, Huayu Yang, Runtao Li, Jingrong Cui
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLipid metabolism and disorders · Ubiquitin and proteasome pathways · Cancer-related molecular mechanisms research
In the published article, there was an error in Figures 3A, B and Figures 4A, C as published. The bands of some proteins shared the same control treated with DMSO vehicle. To avoid misunderstanding, Figures 3A, B and Figures 4A, C were replaced with the images from other repetitive experiments. The corrected Figures 3, 4 and their captions appear below.
In the published article, there was an error in the legends for Figure 3 and Figure 4 as published. The captions were changed to improve clarity. The corrected legends appear below.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.